annual net income:
$8.03B+$5.91B(+279.00%)Summary
- As of today (April 12, 2025), PFE annual net profit is $8.03 billion, with the most recent change of +$5.91 billion (+279.00%) on December 1, 2024.
- During the last 3 years, PFE annual net income has fallen by -$13.95 billion (-63.46%).
- PFE annual net income is now -74.40% below its all-time high of $31.37 billion, reached on December 31, 2022.
Performance
PFE Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$410.00M-$4.05B(-90.82%)Summary
- As of today (April 12, 2025), PFE quarterly net profit is $410.00 million, with the most recent change of -$4.05 billion (-90.82%) on December 1, 2024.
- Over the past year, PFE quarterly net income has stayed the same.
- PFE quarterly net income is now -97.09% below its all-time high of $14.10 billion, reached on June 30, 2013.
Performance
PFE quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$8.03B+$3.78B(+88.88%)Summary
- As of today (April 12, 2025), PFE TTM net profit is $8.03 billion, with the most recent change of +$3.78 billion (+88.88%) on December 1, 2024.
- Over the past year, PFE TTM net income has stayed the same.
- PFE TTM net income is now -74.40% below its all-time high of $31.37 billion, reached on December 31, 2022.
Performance
PFE TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
PFE Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +279.0% | 0.0% | 0.0% |
| 3 y3 years | -63.5% | 0.0% | 0.0% |
| 5 y5 years | -49.9% | 0.0% | 0.0% |
PFE Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -74.4% | +279.0% | -95.9% | +112.2% | -74.4% | +409.5% |
| 5 y | 5-year | -74.4% | +279.0% | -95.9% | +112.2% | -74.4% | +409.5% |
| alltime | all time | -74.4% | +1481.2% | -97.1% | +111.4% | -74.4% | +409.5% |
Pfizer Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $8.03B(+279.0%) | $410.00M(-90.8%) | $8.03B(+88.9%) |
| Sep 2024 | - | $4.46B(>+9900.0%) | $4.25B(-263.9%) |
| Jun 2024 | - | $41.00M(-98.7%) | -$2.60B(+739.8%) |
| Mar 2024 | - | $3.12B(-192.5%) | -$309.00M(-114.6%) |
| Dec 2023 | $2.12B(-93.2%) | -$3.37B(+41.4%) | $2.12B(-79.8%) |
| Sep 2023 | - | -$2.38B(-202.4%) | $10.48B(-51.2%) |
| Jun 2023 | - | $2.33B(-58.0%) | $21.47B(-26.1%) |
| Mar 2023 | - | $5.54B(+11.0%) | $29.05B(-7.4%) |
| Dec 2022 | $31.37B(+42.7%) | $4.99B(-42.0%) | $31.37B(+5.4%) |
| Sep 2022 | - | $8.61B(-13.1%) | $29.77B(+1.6%) |
| Jun 2022 | - | $9.91B(+26.0%) | $29.31B(+17.4%) |
| Mar 2022 | - | $7.86B(+131.8%) | $24.97B(+13.6%) |
| Dec 2021 | $21.98B(+140.0%) | $3.39B(-58.3%) | $21.98B(+13.1%) |
| Sep 2021 | - | $8.15B(+46.4%) | $19.43B(+52.3%) |
| Jun 2021 | - | $5.56B(+14.1%) | $12.76B(+19.4%) |
| Mar 2021 | - | $4.88B(+476.5%) | $10.68B(+16.6%) |
| Dec 2020 | $9.16B(-42.8%) | $846.00M(-42.4%) | $9.16B(+18.5%) |
| Sep 2020 | - | $1.47B(-57.9%) | $7.73B(-44.6%) |
| Jun 2020 | - | $3.49B(+4.0%) | $13.94B(-10.0%) |
| Mar 2020 | - | $3.35B(-675.5%) | $15.50B(-3.3%) |
| Dec 2019 | $16.03B(+43.7%) | -$583.00M(-107.6%) | $16.03B(-1.2%) |
| Sep 2019 | - | $7.68B(+52.2%) | $16.22B(+28.2%) |
| Jun 2019 | - | $5.05B(+29.9%) | $12.65B(+10.2%) |
| Mar 2019 | - | $3.88B(-1088.3%) | $11.48B(+2.9%) |
| Dec 2018 | $11.15B(-47.7%) | -$393.00M(-109.6%) | $11.15B(-53.2%) |
| Sep 2018 | - | $4.11B(+6.3%) | $23.82B(+5.7%) |
| Jun 2018 | - | $3.87B(+8.7%) | $22.55B(+3.7%) |
| Mar 2018 | - | $3.56B(-71.0%) | $21.75B(+2.1%) |
| Dec 2017 | $21.31B(+195.3%) | $12.27B(+332.2%) | $21.31B(+117.2%) |
| Sep 2017 | - | $2.84B(-7.6%) | $9.81B(+17.8%) |
| Jun 2017 | - | $3.07B(-1.5%) | $8.32B(+14.1%) |
| Mar 2017 | - | $3.12B(+302.7%) | $7.30B(+1.2%) |
| Dec 2016 | $7.21B(+3.7%) | $775.00M(-42.8%) | $7.21B(+15.1%) |
| Sep 2016 | - | $1.35B(-33.8%) | $6.27B(-11.0%) |
| Jun 2016 | - | $2.05B(-32.6%) | $7.04B(-7.6%) |
| Mar 2016 | - | $3.04B(-1866.3%) | $7.62B(+9.5%) |
| Dec 2015 | $6.96B(-23.8%) | -$172.00M(-108.1%) | $6.96B(-16.7%) |
| Sep 2015 | - | $2.13B(-18.9%) | $8.36B(-6.0%) |
| Jun 2015 | - | $2.63B(+10.5%) | $8.90B(-3.1%) |
| Mar 2015 | - | $2.38B(+93.5%) | $9.18B(+0.5%) |
| Dec 2014 | $9.13B(-58.5%) | $1.23B(-53.9%) | $9.13B(-12.8%) |
| Sep 2014 | - | $2.67B(-8.4%) | $10.47B(+0.7%) |
| Jun 2014 | - | $2.91B(+25.0%) | $10.40B(-51.8%) |
| Mar 2014 | - | $2.33B(-9.3%) | $21.58B(-1.9%) |
| Dec 2013 | $22.00B(+51.0%) | $2.57B(-0.8%) | $22.00B(-14.6%) |
| Sep 2013 | - | $2.59B(-81.6%) | $25.75B(-2.3%) |
| Jun 2013 | - | $14.10B(+412.5%) | $26.37B(+69.8%) |
| Mar 2013 | - | $2.75B(-56.5%) | $15.53B(+6.6%) |
| Dec 2012 | $14.57B(+45.6%) | $6.32B(+96.9%) | $14.57B(+50.3%) |
| Sep 2012 | - | $3.21B(-1.4%) | $9.69B(-5.2%) |
| Jun 2012 | - | $3.25B(+81.3%) | $10.22B(+6.7%) |
| Mar 2012 | - | $1.79B(+24.7%) | $9.58B(-4.3%) |
| Dec 2011 | $10.01B(+21.2%) | $1.44B(-61.5%) | $10.01B(-12.7%) |
| Sep 2011 | - | $3.74B(+43.2%) | $11.46B(+33.4%) |
| Jun 2011 | - | $2.61B(+17.5%) | $8.59B(+1.6%) |
| Mar 2011 | - | $2.22B(-23.1%) | $8.45B(+2.4%) |
| Dec 2010 | $8.26B(-4.4%) | $2.89B(+233.7%) | $8.26B(+34.6%) |
| Sep 2010 | - | $866.00M(-65.0%) | $6.13B(-24.7%) |
| Jun 2010 | - | $2.48B(+22.2%) | $8.15B(+2.7%) |
| Mar 2010 | - | $2.03B(+164.1%) | $7.93B(-8.1%) |
| Dec 2009 | $8.63B(+6.6%) | $767.00M(-73.3%) | $8.63B(+6.2%) |
| Sep 2009 | - | $2.88B(+27.3%) | $8.13B(+8.0%) |
| Jun 2009 | - | $2.26B(-17.1%) | $7.53B(-6.4%) |
| Mar 2009 | - | $2.73B(+925.9%) | $8.05B(-0.7%) |
| Dec 2008 | $8.10B(-0.5%) | $266.00M(-88.3%) | $8.10B(-23.3%) |
| Sep 2008 | - | $2.28B(-17.9%) | $10.56B(+16.8%) |
| Jun 2008 | - | $2.78B(-0.3%) | $9.04B(+20.0%) |
| Mar 2008 | - | $2.78B(+2.2%) | $7.54B(-7.5%) |
| Dec 2007 | $8.14B(-57.9%) | $2.72B(+258.0%) | $8.14B(-45.2%) |
| Sep 2007 | - | $761.00M(-39.9%) | $14.87B(-14.9%) |
| Jun 2007 | - | $1.27B(-62.6%) | $17.47B(-6.2%) |
| Mar 2007 | - | $3.39B(-64.1%) | $18.62B(-3.7%) |
| Dec 2006 | $19.34B(+139.2%) | $9.45B(+181.1%) | $19.34B(+53.2%) |
| Sep 2006 | - | $3.36B(+39.2%) | $12.62B(+16.3%) |
| Jun 2006 | - | $2.42B(-41.3%) | $10.85B(-8.8%) |
| Mar 2006 | - | $4.11B(+50.4%) | $11.90B(+47.1%) |
| Dec 2005 | $8.09B(-28.8%) | $2.73B(+72.0%) | $8.09B(-1.1%) |
| Sep 2005 | - | $1.59B(-54.1%) | $8.18B(-17.6%) |
| Jun 2005 | - | $3.46B(+1050.5%) | $9.93B(+6.4%) |
| Mar 2005 | - | $301.00M(-89.3%) | $9.33B(-17.9%) |
| Dec 2004 | $11.36B | $2.83B(-15.4%) | $11.36B(+24.3%) |
| Sep 2004 | - | $3.34B(+16.7%) | $9.14B(+13.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $2.86B(+22.8%) | $8.03B(+409.3%) |
| Mar 2004 | - | $2.33B(+287.2%) | $1.58B(-59.7%) |
| Dec 2003 | $3.91B(-57.2%) | $602.00M(-73.1%) | $3.91B(-36.6%) |
| Sep 2003 | - | $2.23B(-162.2%) | $6.17B(-1.8%) |
| Jun 2003 | - | -$3.59B(-177.0%) | $6.28B(-46.9%) |
| Mar 2003 | - | $4.67B(+63.3%) | $11.83B(+29.6%) |
| Dec 2002 | $9.13B(+17.2%) | $2.86B(+21.5%) | $9.13B(+10.9%) |
| Sep 2002 | - | $2.35B(+20.1%) | $8.23B(+3.5%) |
| Jun 2002 | - | $1.96B(-0.3%) | $7.95B(+1.6%) |
| Mar 2002 | - | $1.96B(+0.4%) | $7.82B(+0.4%) |
| Dec 2001 | $7.79B(+109.0%) | $1.96B(-5.6%) | $7.79B(+7.4%) |
| Sep 2001 | - | $2.07B(+13.3%) | $7.25B(+10.9%) |
| Jun 2001 | - | $1.83B(-5.2%) | $6.54B(+11.6%) |
| Mar 2001 | - | $1.93B(+35.9%) | $5.86B(+57.3%) |
| Dec 2000 | $3.73B(-24.8%) | $1.42B(+4.3%) | $3.73B(-1.3%) |
| Sep 2000 | - | $1.36B(+18.3%) | $3.78B(+7.2%) |
| Jun 2000 | - | $1.15B(-663.7%) | $3.52B(-0.3%) |
| Mar 2000 | - | -$204.00M(-113.9%) | $3.53B(-22.4%) |
| Dec 1999 | $4.95B(+6.9%) | $1.47B(+32.6%) | $4.55B(-8.9%) |
| Sep 1999 | - | $1.11B(-4.6%) | $5.00B(-5.5%) |
| Jun 1999 | - | $1.16B(+42.5%) | $5.29B(+11.2%) |
| Mar 1999 | - | $815.00M(-57.5%) | $4.76B(+2.7%) |
| Dec 1998 | $4.63B(+109.4%) | $1.92B(+37.2%) | $4.63B(+41.5%) |
| Sep 1998 | - | $1.40B(+122.5%) | $3.27B(+32.4%) |
| Jun 1998 | - | $628.00M(-9.2%) | $2.47B(+7.4%) |
| Mar 1998 | - | $692.00M(+24.0%) | $2.30B(+4.1%) |
| Dec 1997 | $2.21B(+14.7%) | $558.00M(-6.4%) | $2.21B(+2.5%) |
| Sep 1997 | - | $596.00M(+30.4%) | $2.16B(+3.9%) |
| Jun 1997 | - | $457.00M(-24.1%) | $2.08B(+3.1%) |
| Mar 1997 | - | $602.00M(+19.4%) | $2.01B(+4.4%) |
| Dec 1996 | $1.93B(+22.6%) | $504.00M(-1.9%) | $1.93B(+5.1%) |
| Sep 1996 | - | $514.00M(+30.5%) | $1.84B(+5.1%) |
| Jun 1996 | - | $394.00M(-23.8%) | $1.75B(+4.7%) |
| Mar 1996 | - | $517.00M(+25.8%) | $1.67B(+6.1%) |
| Dec 1995 | $1.57B(+21.1%) | $410.90M(-3.4%) | $1.57B(+5.1%) |
| Sep 1995 | - | $425.30M(+34.5%) | $1.50B(+6.3%) |
| Jun 1995 | - | $316.30M(-24.8%) | $1.41B(+4.4%) |
| Mar 1995 | - | $420.40M(+25.9%) | $1.35B(+3.8%) |
| Dec 1994 | $1.30B(+97.5%) | $334.00M(-0.7%) | $1.30B(+3.6%) |
| Sep 1994 | - | $336.50M(+30.8%) | $1.25B(+78.4%) |
| Jun 1994 | - | $257.20M(-30.6%) | $702.60M(+0.5%) |
| Mar 1994 | - | $370.70M(+28.3%) | $699.20M(+6.3%) |
| Dec 1993 | $657.50M(-18.9%) | $288.90M(-234.9%) | $657.50M(+71.6%) |
| Sep 1993 | - | -$214.20M(-184.4%) | $383.10M(-57.2%) |
| Jun 1993 | - | $253.80M(-22.9%) | $894.80M(+5.9%) |
| Mar 1993 | - | $329.00M(+2169.0%) | $844.80M(+4.2%) |
| Dec 1992 | $810.90M(+12.3%) | $14.50M(-95.1%) | $810.90M(+1.7%) |
| Sep 1992 | - | $297.50M(+46.0%) | $797.30M(+2.9%) |
| Jun 1992 | - | $203.80M(-30.9%) | $774.50M(+3.3%) |
| Mar 1992 | - | $295.10M(>+9900.0%) | $749.80M(+3.8%) |
| Dec 1991 | $722.10M(-9.9%) | $900.00K(-99.7%) | $722.10M(-17.6%) |
| Sep 1991 | - | $274.70M(+53.4%) | $876.00M(+3.7%) |
| Jun 1991 | - | $179.10M(-33.0%) | $844.60M(+3.4%) |
| Mar 1991 | - | $267.40M(+72.7%) | $816.70M(+1.9%) |
| Dec 1990 | $801.20M(+17.6%) | $154.80M(-36.4%) | $801.20M(+9.2%) |
| Sep 1990 | - | $243.30M(+60.9%) | $733.50M(+3.6%) |
| Jun 1990 | - | $151.20M(-40.0%) | $707.70M(+2.2%) |
| Mar 1990 | - | $251.90M(+189.2%) | $692.20M(+1.6%) |
| Dec 1989 | $681.10M(-13.9%) | $87.10M(-60.0%) | $681.10M(-7.4%) |
| Sep 1989 | - | $217.50M(+60.3%) | $735.60M(+0.1%) |
| Jun 1989 | - | $135.70M(-43.6%) | $734.90M(-9.5%) |
| Mar 1989 | - | $240.80M(+70.1%) | $812.30M(+2.7%) |
| Dec 1988 | $791.30M(+14.6%) | $141.60M(-34.7%) | $791.30M(+0.6%) |
| Sep 1988 | - | $216.80M(+1.7%) | $786.30M(+4.1%) |
| Jun 1988 | - | $213.10M(-3.0%) | $755.30M(+5.2%) |
| Mar 1988 | - | $219.80M(+60.9%) | $718.00M(+4.0%) |
| Dec 1987 | $690.20M(+4.6%) | $136.60M(-26.5%) | $690.20M(-3.1%) |
| Sep 1987 | - | $185.80M(+5.7%) | $712.00M(+1.3%) |
| Jun 1987 | - | $175.80M(-8.4%) | $702.80M(+2.9%) |
| Mar 1987 | - | $192.00M(+21.2%) | $683.10M(+3.5%) |
| Dec 1986 | $660.00M(+13.9%) | $158.40M(-10.3%) | $660.00M(+3.0%) |
| Sep 1986 | - | $176.60M(+13.1%) | $640.90M(+3.4%) |
| Jun 1986 | - | $156.10M(-7.6%) | $619.80M(+3.1%) |
| Mar 1986 | - | $168.90M(+21.2%) | $601.20M(+3.7%) |
| Dec 1985 | $579.70M(+14.1%) | $139.30M(-10.4%) | $579.60M(+1.8%) |
| Sep 1985 | - | $155.50M(+13.1%) | $569.60M(+4.2%) |
| Jun 1985 | - | $137.50M(-6.7%) | $546.90M(+3.7%) |
| Mar 1985 | - | $147.30M(+13.9%) | $527.50M(+3.9%) |
| Dec 1984 | $507.90M | $129.30M(-2.6%) | $507.90M(+34.2%) |
| Sep 1984 | - | $132.80M(+12.4%) | $378.60M(+54.0%) |
| Jun 1984 | - | $118.10M(-7.5%) | $245.80M(+92.5%) |
| Mar 1984 | - | $127.70M | $127.70M |
FAQ
- What is Pfizer annual net profit?
- What is the all time high annual net income for Pfizer?
- What is Pfizer annual net income year-on-year change?
- What is Pfizer quarterly net profit?
- What is the all time high quarterly net income for Pfizer?
- What is Pfizer quarterly net income year-on-year change?
- What is Pfizer TTM net profit?
- What is the all time high TTM net income for Pfizer?
- What is Pfizer TTM net income year-on-year change?
What is Pfizer annual net profit?
The current annual net income of PFE is $8.03B
What is the all time high annual net income for Pfizer?
Pfizer all-time high annual net profit is $31.37B
What is Pfizer annual net income year-on-year change?
Over the past year, PFE annual net profit has changed by +$5.91B (+279.00%)
What is Pfizer quarterly net profit?
The current quarterly net income of PFE is $410.00M
What is the all time high quarterly net income for Pfizer?
Pfizer all-time high quarterly net profit is $14.10B
What is Pfizer quarterly net income year-on-year change?
Over the past year, PFE quarterly net profit has changed by $0.00 (0.00%)
What is Pfizer TTM net profit?
The current TTM net income of PFE is $8.03B
What is the all time high TTM net income for Pfizer?
Pfizer all-time high TTM net profit is $31.37B
What is Pfizer TTM net income year-on-year change?
Over the past year, PFE TTM net profit has changed by $0.00 (0.00%)